life science connect's re-brand announcement

OUTSOURCING INSIGHTS

  • From Cold To Controlled
    From Cold To Controlled

    World Courier Ground Europe reveals impressive test results for new fleet of temperature-controlled vehicles.

  • Drug Developments’ PR Problem
    Drug Developments’ PR Problem

    We went into this business to save lives. So why does it feel we’re always portrayed as the guys in the black hats?

  • Profiling Metal Content In Parenteral Grade Protein Stabilizers
    Profiling Metal Content In Parenteral Grade Protein Stabilizers

    As the demand for parenteral excipients continues to rise, the biopharma industry is considering guidance that would require more extensive analysis of a variety of minor constituents, including metals.

  • The Impact Of The Surging Biotech Market On New Startups And CMO Outsourcing
    The Impact Of The Surging Biotech Market On New Startups And CMO Outsourcing

    The biotechnology market sector has experienced stellar performance in recent years, outperforming the S&P 500 and most other market segments. In just under three years, the NASDAQ Biotechnology Index (BMI) has risen over 180 percent, climbing 32 percent, 65 percent, and 34 percent (as of Dec 1, 2014) in 2012, 2013, and 2014 respectively. First quarter 2014 kicked off with 23 Biotech IPOs, the strongest first quarter performance since 2000. With such strong market demand for new biotech companies with innovative assets, most analysts believe the outlook for the sector remains quite promising. This would potentially seem like good news for contract manufacturing organizations (CMOs) as market enthusiasm and gains would be expected to stimulate investment in new biotechnology startup companies.

  • A New Approach To Laboratory Efficiency: On-site Instrument Concierge Service
    A New Approach To Laboratory Efficiency: On-site Instrument Concierge Service

    Scientists are spending an enormous amount of their time and effort simply getting instrumentation to the point that it can be used,” the NRC reports. “This wasted time can be used more productively when a well-functioning repair and maintenance system is in place.

  • Keeping The Right Chemistry In Compound Procurement
    Keeping The Right Chemistry In Compound Procurement

    What happens when virtual screening libraries meet the real world?

    Virtual screening libraries can be brilliantly designed to deliver the best range of chemistry for your wet screen, but when the virtual meets the real, things get more complicated. Including computational chemistry in the procurement process means that you can move from virtual screening to plated compounds and still keep the best of both worlds.

    Delivering a plated library of screening compounds is a more complex process than first meets the eye and involves a series of sometimes conflicting requirements. First and foremost, the compounds must include the right chemistry. Virtual screening is an excellent way to design an optimum set of compounds, but the complexities of the procurement process often means that the best compounds cannot be obtained on time and within budget. Offsetting pricing, availability and shipping overheads from multiple vendors is a major logistical challenge and often leads to compromises in the chemical diversity of the final purchased set.

More Insights

OUTSOURCED PHARMA CONTRIBUTING EDITORS

  • Is A Customer-Centric Strategy A Fit For Pharmaceutical Manufacturing?

    In an industry such as pharmaceutical manufacturing, which typically focuses on improving operational excellence or coming up with the next big drug, is a business strategy with a customer-first focus the right fit?

  • Lilly Moves From Patent Expirations To New Product Growth

    Eli Lilly and Company has announced its 2015 financial guidance and outlined growth plans for the remainder of the decade. The company’s refined strategy places an emphasis on growing revenue and expanding margins by providing a greater focus on research and commercial activities, while maintaining a sustainable flow of innovative medicines.

    "We are successfully moving from a challenging period of patent expirations to a period of resumed growth, led by diabetes, oncology and animal health," says John C. Lechleiter, Ph.D., Lilly's chairman, president, and CEO. "We are launching new products and competing more effectively. We also retain one of the strongest pipelines in our history. Our refined strategic direction gives us a blueprint that will provide greater focus for our research and commercial activities and help Lilly respond to an ever more challenging environment. In these ways and more, we'll continue to create value for all our stakeholders while improving the lives of patients."

  • Will More Capitalism Save Pharma?

    Capitalism for some people is equated with greed. Whether this notion is born from increasing consumer resentment towards corporate profits, or perhaps that iconic Gordon Gekko speech in the 1987 movie Wall Street still resonates, capitalism seems to be under greater attack with each passing year. Unfortunately, along with greater resentment of capitalism comes ever increased oversight by government agencies seeking to correct perceived wrongs caused by free markets.

    In the December 29th, 2014 issue of Forbes magazine, editor-in-chief Steve Forbes makes the case for capitalism, specifically from the perspective of the pharmaceutical industry. Forbes gives two examples to back up his stance.

  • Bayer Change Notification Process For Raw Material Supply Encourages Supplier Collaboration And Transparency

    When it comes to raw material supply, increased regulatory focus on the raw material supply chain is creating a transformational change in the industry. Because of this, quality agreements create a responsibility among suppliers to notify their partners with advanced notice any time a change is made to the raw materials those partners are receiving. To ensure change notifications are handled properly and evaluated thoroughly, Bayer Healthcare utilizes an internal process that allows notifications to be filtered to the appropriate stakeholder and reviewed thoroughly before action is taken. Albert Obrero, Jr., Senior Project Specialist at Bayer HealthCare, recently presented the Bayer process to an audience at Bioprocess International 2014, where he outlined how it works as well as its benefits.

  • The Impact Of The Surging Biotech Market On New Startups And CMO Outsourcing

    The biotechnology market sector has experienced stellar performance in recent years, outperforming the S&P 500 and most other market segments. In just under three years, the NASDAQ Biotechnology Index (BMI) has risen over 180 percent, climbing 32 percent, 65 percent, and 34 percent (as of Dec 1, 2014) in 2012, 2013, and 2014 respectively. First quarter 2014 kicked off with 23 Biotech IPOs, the strongest first quarter performance since 2000. With such strong market demand for new biotech companies with innovative assets, most analysts believe the outlook for the sector remains quite promising. This would potentially seem like good news for contract manufacturing organizations (CMOs) as market enthusiasm and gains would be expected to stimulate investment in new biotechnology startup companies.

More From Contributing Editors...

FEATURED SUPPLIERS

  • Baxter BioPharma Solutions
    Baxter BioPharma Solutions

    BioPharma Solutions, a business unit of Baxter, partners with pharmaceutical companies to support their commercialization objectives by providing scientific expertise, sterile contract manufacturing solutions, parenteral delivery systems, and customized support services needed to meet the unique challenges that parenteral products face.

  • Pfanstiehl, Inc.
    Pfanstiehl, Inc.

    Pfanstiehl is the premier manufacturer of cGMP high purity, low endotoxin injectable grade excipients and biopharmaceutical components for upstream bioprocessing, downstream formulation, and specialty applications. In addition, Pfanstiehl is a leading contract development and manufacturing organization (CDMO) specializing in the isolation, purification, custom synthesis and scale-up development of small molecule Active Pharmaceutical Ingredients (API), in gram to multi-ton commercial quantities. While most ingredient manufacturers or resellers focus on other industries such as food, cosmetics, agriculture, and/or nutritional supplements, offering only a subset of “pharma grade” ingredients, Pfanstiehl is Pharma Grade through and through. It’s all we do. Pfanstiehl’s ICH Q7 compliant manufacturing facility is centrally located just north of Chicago, and only 35 minutes by car from O’Hare International Airport.

  • MPI Research
    MPI Research

    MPI Research, with global headquarters in Mattawan, Michigan, provides discovery, safety evaluation, bioanalytical, and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries.

  • World Courier Management
    World Courier Management

    World Courier is the largest, most successful specialty courier company in the world. World Courier pioneered the offering of specialty logistics services for the medical and bio-pharmaceutical communities, transporting the first human heart tissue for transplant in 1984.

  • UPM Pharmaceuticals
    UPM Pharmaceuticals

    At UPM Pharmaceuticals, scientific sophistication and experience come together with flexibility, responsiveness and innovation. UPM provides pharmaceutical drug development services including formulation development, GMP clinical and commercial manufacturing, analytical methods development and stability testing.

Newsletter Signup
Newsletter Signup
By clicking Sign Me Up, you agree to our Terms and that you have read our Privacy Policy.

 UPCOMING TRAINING COURSES

Monitoring Informed Consent (IC): Frequently Asked Questions

February 2, 2015
1pm-2:30pm EST, Online Training

Regulatory Affairs for Biologics – A Compliance Primer

February 4, 2015
1pm-2:30pm EST, Online Training

Surviving a FDA GCP Inspection – Preparation Techniques for Success

February 5, 2015
1pm-2:30pm EST, Online Training

FDA Guidance on Social Media: Questions Answered and Unanswered

February 10, 2015
1pm-2:30pm EST, Online Training

Strategic Clinical Project Management: Principles and Practical Applications

February 11, 2015
1pm-2:30pm EDT, Online Training
More Upcoming Courses

NORTHERN CALIFORNIA’S LIFE SCIENCE ASSOCIATION

feed image
more BayBio events...

FIND A CRO IN SOUTHERN CALIFORNIA

find a cro in drug development

Find a CRO with BIOCOM’s drug development guide which provides a description of each phase along with a list of companies that can accommodate your needs in the drug development cycle.

Get more info....

OUTSOURCING EVENTS

Monitoring Informed Consent (IC): Frequently Asked Questions

February 2, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Regulatory Affairs for Biologics – A Compliance Primer

February 4, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Surviving a FDA GCP Inspection – Preparation Techniques for Success

February 5, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

FDA Guidance on Social Media: Questions Answered and Unanswered

February 10, 2015
1pm-2:30pm EST, Online Training
Price:  $299 - Introductory Rate

Strategic Clinical Project Management: Principles and Practical Applications

February 11, 2015
1pm-2:30pm EDT, Online Training
Price:  $299 - Introductory Rate
More Events...

ABOUT US

Welcome to OutsourcedPharma.com, the website dedicated to pharmaceutical drug development services. With regular sections on pharmaceutical drug development, contract manufacturing, contract research services, contract packaging services, formulation & development services, contract analytical testing, API (Active Pharmaceutical Ingredients) manufacturing, stability testing services  and other areas in pharmaceutical contract development and manufacturing, we bring complete coverage of outsourcing trends and issues to the pharmaceutical contract development and manufacturing marketplace.

Use our supplier directory and offline search service to expedite your discovery of CMOs, CDMOs, CROs, and functional service providers. Please take a moment to join our community and discover the benefits of your free membership.

Outsourced Pharma is part of the Life Science Connect media group. The vision of Life Science Leader and Life Science Connect is to help facilitate connections and foster collaborations in pharmaceutical and medical device development to find ways to get more life-saving and life-improving therapies to market in an efficient manner. Connect, Collaborate, Contribute.